Retrophin (RTRX +10.2%) shares surge just a nickel short of a 52-week high after a pair of investment funds disclosed a combined 12.5% stake in the biotech company.
Retrophin +10% after SAC Capital, Broadfin disclose new stakes
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs